Kenvue price target lowered to $23 from $25 at Jefferies

Jefferies analyst Keith Devas lowered the firm’s price target on Kenvue (KVUE) to $23 from $25 and keeps a Buy rating on the shares. Macro headwinds continue to be felt more acutely in consumer health than other pockets of staples, says the analyst, who lowered targets and estimates across the firm’s consumer health coverage into Q3 earnings reports from the group.